Letter: biologics treatment in Crohn's disease and risk of bowel resection—what about the patients who stop anti‐TNF therapy?

Letter: biologics treatment in Crohn's disease and risk of bowel resection—what about the patients who stop anti‐TNF therapy?

Linked Content This article is linked to Eberhardson et al papers. To view these articles visit https://doi.org/10.1111/apt.14224 and https://doi.org/10.1111/apt.14398.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2018-01, Vol.47 (1), p.146-147
Hauptverfasser: Ribaldone, D. G., Saracco, G., Astegiano, M., Pellicano, R.
Format: Artikel
Sprache:eng
Schlagworte:
Crohn's disease
Health risks
Intestine
Medical treatment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linked Content This article is linked to Eberhardson et al papers. To view these articles visit https://doi.org/10.1111/apt.14224 and https://doi.org/10.1111/apt.14398.
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.14321